Geert Day To You!


Clinical Trial Site Updated

The CT Site was just updated.  But this update is very different.  All past updates have been done in 3 month increments to match a quarter end date.


HOWEVER...


Today's update is to May 15, 2020.  


Just 5 weeks away.


This is NOT a month end nor is it to the next quarter, June 30.


Geerty Up!  The End is Near!



CEL-SCI IS HIRING!!!!!!!

Why is a small  Biotech with limited cash resources hiring manufacturing  positions? Why would they incur the costs to hire, train and pay new employees at this juncture?


Per the recent Zacks article, they have already hired 7 employees since 1/1/20 and are now looking to add 4 more!


This is not normal...This is BULLISH!!!!!


READ ABOUT IT HERE

H.C Wainwright Initiates Coverage - BUY

On January 13, 2020,  H.C. Wainwright initiates coverage On CEL-SCI to Buy with a PT of $18. 


Funny thing is...we 'bout to blow past that!

Commercial Scale Preparation Has Begun!

In the PR accompanying the 10-Q, the CEO, Geert Kersten, dropped a BOMB!


 "We are therefore preparing for commercial scale production of Multikine at our manufacturing facility,” stated CEL-SCI CEO, Geert Kersten. 

****INSIDER BUYS****

 "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." - Peter Lynch 


On 2/26, 6 insiders purchased shares after the attempted "take down" by those Nasty Shorts!  


On 1/13, Geert buys another $50K! (hint hint. wink wink)


On 10/25, Geert bought another $25K!


On 9/4, the Geert and 2 others purchased another $57K. 


On  6/3,  Geert  bought  MORE!  He  bought  another $25K


On 5/7,  Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined  Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "


Furthermore, on 5/21 Peter Young bought another $10K on the open market.


All Insider Transactions can be seen here.

CNBC'S JIM CRAMER DISCUSSES CEL-SCI, AGAIN!!!!!

On February 4th, CNBC's Jim Cramer AGAIN gives another ***BUY*** for CVM!!!


 "This is one I'm in favor of, even up here."  


This is the second time in 4 months!


IDMC SAYS CONTINUE!!!!

 The IDMC made the following recommendation on October 15, 2019 


  • The IDMC recommendation “is to continue the trial until the appropriate number of events has occurred”.


The subsequent  8-K said it more succinctly:


  • The IDMC "Recommended to continue the trial until the appropriate number of events has occurred."


READ ABOUT THE IDMC HERE

Why Has CVM Hired Lobbyists?

Why has CEL-SCI contracted with The Petrizzo Group to lobby the FDA/US Government about "FDA approval issues of innovative drug therapies"?


Why spend $100K when cash flow is low?


They lobbied the U.S. Senate, the U.S. House of Reps, the FDA, the Office of Management and Budget and Health & Human Services.


This ain't cheap. They spent $50K in Q3 2019 and $50K in Q4 2019!

CASH CASH BABY

Wow!  Just wow.


Geert has removed the biggest question mark: when and how bad is the offering going to be!


A clean deal!  No warrants.  Low discount. And 15% Greenshoe!


$6M.  They now have over $14M... Enough money until mid Summer of 2020.


The Vulture Shorts were waiting and hoping for toxic financing to save their asses!  F' Them!


Now, there is NO excuse for people to jump into the stock.



MULTIKINE.COM DOMAIN HAS A NEW OWNER!

Andybo from StockTwits brought this to our attention.   Someone bought out the domain name Multikine.com on Friday, Sept 13 before the expiration date, meaning, someone paid $ to buy out the domain from the old owner.  Why now? Why days before the IDMC did this happen?


Who is the new owner?  Multikine.com doesn't redirect to the Cel-Sci.com website....


While we dont know now, time will tell.  Things like this are called "HINTS" 

9/25: ERGOMED SAYS STUDY IS 96% COMPLETE OR DID THEY??

On 9/25, Ergomed released their Interim financial results.  In this presentation, they state the following:


  •  Awaiting Phase III results 
  •  Limited work ongoing on 30 day terms and paid from share sales 
  • 96% complete  


96% complete...not 95% or "First Half of 2019" (like their prior presentation), but 96%.  Why not 95%?


This implies we are at 286 Events!  FOSCO is RIGHT!!!!


******BUT WAIT!!!  Shortly after posting this all over the internet, the Interim Presentation was REMOVED and UPDATED.  It no longer mentions "96% Complete".  


Don't worry, your pal Sushi kept a copy here!


Why did they remove 96%?  Because they fucked up and accidentally released CONFIDENTIAL info.  That's why!


READ THE AMAZING ARTICLE BELOW

Ergomed Insider Transactions

 Dr Miroslav Reljanovic, Executive Chairman of the Company, purchased 200K shares ($775K USD) on 6/24.  Add this to the recent purchases by the COO and CFO brings the total to over $1.2M USD of Insider transactions in the past weeks.


Insider transactions details HERE


For a Deep Dive on the Ergomed and CEL-SCI relationship, please read this Article HERE

Our 15 Minutes of Fame

Aren't we something?  Watch this video talking all about this site!